Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR Distraction in Peripheral Angioplasty
NCT07057752Phase 3Completed
- Sponsor
- Kastamonu University
- Start
- Aug 2025
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Kastamonu University. Primary endpoints: Numerical Rating Scale at 1 day and State Anxiety Inventory-6 at 1 day. Started Aug 2025; status: completed.
Beyond the preview
Go deeper on NCT07057752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07057752.